Today: 20 May 2026
Browse Category

NYSE:PPTA 29 September 2025 - 9 December 2025

Canada Stock Market Today: TSX Edges Higher as Gold and Banks Lead Rally Ahead of Fed and BoC Decisions – December 9, 2025

Canada Stock Market Today: TSX Edges Higher as Gold and Banks Lead Rally Ahead of Fed and BoC Decisions – December 9, 2025

The S&P/TSX Composite Index closed at 31,266 on Tuesday, up 0.3%, staying near last week’s record high. Gold-mining stocks led gains as bullion prices surged, with the gold sub-index up 1.4%. Utilities rose about 0.8%, boosted by a 7% jump in TransAlta shares. Investors positioned ahead of central bank decisions due Wednesday.
9 December 2025
Massive Moves: Record Deals, FDA Wins & Crypto Mania Propel Top Stock Gainers (Sep 29, 2025)

Massive Moves: Record Deals, FDA Wins & Crypto Mania Propel Top Stock Gainers (Sep 29, 2025)

Electronic Arts shares jumped 15% after agreeing to a $55 billion buyout led by Saudi Arabia’s PIF, offering $210 per share. Crinetics Pharmaceuticals soared 28% as the FDA approved its oral acromegaly drug. QMMM Holdings surged 19% before the SEC halted trading over suspected manipulation. Scholar Rock gained 12% despite an FDA delay for its spinal atrophy drug.

Stock Market Today

  • UiPath Shares Dip Amid Microsoft Korea Collaboration and Cloud Automation Expansion
    May 19, 2026, 7:30 PM EDT. UiPath (PATH) shares fell 0.99% to $10.54 on heightened trading volume following a collaboration with Microsoft Korea to launch Automation Cloud locally, aiming to boost regional cloud automation adoption. The initiative offers Korean enterprises local data residency support, crucial for managing sensitive workflows, and aligns with UiPath's shift toward partner-driven cloud sales. Broader market movements saw the S&P 500 drop 0.67% and the Nasdaq Composite decline 0.84%, with key enterprise software peers Microsoft and ServiceNow also closing lower. Investors are watching to see if local deployments in South Korea translate into consistent cloud revenue growth for UiPath.

Latest articles

James Hardie Drops After Warning on Housing, Even With Q4 Beat

James Hardie Drops After Warning on Housing, Even With Q4 Beat

20 May 2026
James Hardie’s U.S.-listed shares dropped 6.1% Tuesday and slid another 2.6% after hours after reporting a 35% fall in quarterly net income to $28.5 million, despite a 45% jump in net sales to $1.40 billion. The company cited weak housing demand and warned the market remains uncertain. ASX shares had not traded post-earnings; they last closed at A$26.78, up 2.9%.
SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

SELLAS Stock Jumps as One Trial Number Puts Cancer Readout in Focus

20 May 2026
SELLAS Life Sciences shares rose 4.1% to $7.59 Tuesday after CEO Angelos Stergiou said its Phase 3 AML trial is two events from final analysis. The company reported $107.1 million in cash and a first-quarter net loss of $8.4 million. The REGAL trial’s main measure is overall survival. SELLAS remains blinded to results until the 80th event triggers data review.
Red Robin Shares Rise After Earnings Beat

Red Robin Shares Rise After Earnings Beat

20 May 2026
Red Robin shares surged 15.6% after hours to $4.45 Tuesday, following first-quarter revenue of $378.3 million that beat Wall Street estimates despite a 0.6% drop in comparable sales and a 1.6% decline in guest traffic. Net loss was $2.2 million, or 12 cents per share. The company reaffirmed its 2026 outlook and said refranchising talks are in final stages.
Go toTop